Jingzhou Ruidong Pharmaceutical Technology Co., Ltd. was established in 2021, covering an area of 100 acres. Located in the beautiful city of Jingzhou, the company specializes in the production and research of imidazole-based antifungal active pharmaceutical ingredients (APIs). It primarily undertakes the production and sales of APIs and intermediates for major overseas pharmaceutical companies. The company boasts modern production facilities and advanced manufacturing equipment. Currently, it operates three production workshops with an annual capacity of 1,500 tons. It is also equipped with a high-level laboratory and has established a close collaborative relationship with the doctoral research laboratory of Central South University in Hunan.

Since its establishment, the company has rapidly become a leading API manufacturer in China, thanks to its strong R&D capabilities, reliable production technology, and high-quality products.

In the future, Jingzhou Ruidong Pharmaceutical Technology Co., Ltd. will continue to deepen its expertise in the field of imidazole-based antifungal APIs and expand its business scope. The company's R&D projects will primarily focus on three major areas: antifungal biological medications, veterinary pharmaceuticals, and cholesterol-lowering drugs. At the same time, the company will closely monitor market demands and expand the production of various APIs urgently needed by the market to meet the needs of diverse customers in the pharmaceutical industry, both now and in the future.